This safety update report is based on detailed analysis of data up to 28 February 2021. At this date, an estimated 10.7 million first doses of the Pfizer/BioNTech vaccine and 9.7 million doses of the Oxford University/AstraZeneca vaccine had been administered, and around 0.8 million second doses, mostly the Pfizer/BioNTech vaccine, had been administered...
https://www.gov.uk/government/publicati ... -reporting

16% Chance of Thrombosis at Covid19 Hospitalization:
https://pubmed.ncbi.nlm.nih.gov/32702090/

While no exact epidemiological data are available, the incidence of PE is estimated to be approximately 60 to 70 per 100,000, and that of venous thrombosis approximately 124 per 100,000 of the general population (1,2). The European guidelines for the diagnosis and management of PE report annual incidence rates of venous thrombosis and PE of approximately 0.5 to 1.0 per 1000 inhabitants (3). However, the actual figures are likely to be substantially higher because silent PE can develop in up to 40% to 50% of patients with deep vein thrombosis (DVT) (4). In addition, autopsy studies have shown that PE had been diagnosed before death in 30% to 45% of patients (5). After coronary artery disease and stroke, acute PE ranks third among the most common types of cardiovascular diseases. While clinical data indicate that most cases of PE occur at 60 to 70 years of age, autopsy data show the highest incidence among individuals 70 to 80 years of age. If untreated, acute PE is associated with a significant mortality rate (as high as 30%), whereas the death rate of diagnosed and treated PE is 8%. Up to 10% of acute PE patients die suddenly. Two of three patients succumbing to PE die within 2 h after presentation. The mortality rates associated with various types of PE are summarized in (Table 1) (2,3,6).

Njemačka obustavila upotrebu AstraZeneca vakcine protiv koronavirusa

Njemačka vlada objavila je u ponedjeljak da obustavlja upotrebu vakcine AstraZeneca protiv koronavirusa zbog novih izvještaja o opasnim krvnim ugrušcima.
https://bit.ly/3tjVkHm

Italija i Francsuka objavile su da privremeno obustavljaju korištenje cjepiva AstraZenece protiv covida-19 http://bit.ly/3vsiZY8

Hm. Sve je to čudno ako se pogledaju gornje analize iz GB.

Prema Institutu Robert Koch, više od 2,8 milijuna ljudi sada je barem jednom cijepljeno Astra Zenecom - nakon čega je u 31 slučaju zabilježena tromboza vene sinusa. Ovo je krvni ugrušak u glavnom odvodnom dijelu mozga. Izuzev dva slučaja, sva izvješća odnosila su se na žene u dobi od 20 do 63 godine. Dvojica muškaraca imala su 36 i 57 godina. U 19 slučajeva, uz trombozu vena sinusa, dogodila se i trombocitopenija, tj. Gubitak krvnih pločica odgovornih za zgrušavanje krvi. Ishod je bio koban u devet slučajeva.

Do danas je u Velikoj Britaniji zabilježeno pet slučajeva tromboze cerebralnih vena povezanih s cijepljenjem. Jedna osoba je preminula. No, za razliku od ostatka Europe, očito su to pogođeni samo muškarci. Jedanaest milijuna ljudi u Velikoj Britaniji već je cijepljeno - svi s aktivnim sastojkom Astra Zenece. U Walesu, gdje je cijepljeno 440 000 ljudi, nije bilo tromboza povezanih s cijepljenjem, pokazalo je istraživanje Sveučilišta Swansea. 180.000 ljudi u Walesu cijepljeno je cjepivom Astrazeneca. Još 260 000 primilo je cjepivo od Biontech / Pfizer.

Do 24. ožujka primili smo 22 izvješća o cerebralnoj venskoj sinusnoj trombozi (CVST) i 8 izvještaja o drugim događajima s niskom trombocitom, od ukupno 18,1 milijuna doza cjepiva AstraZeneca COVID-19 primijenjenih do tog datuma. Nije bilo izvještaja o cjepivu Pfizer / BioNTech. Napominjemo da trenutni ispisi analize sadrže podatke do 21. ožujka...

https://www.gov.uk/government/publicati ... -reporting

Zvaničnik EMA potvrdio povezanost AstraZenece i pojave trombova
Sada to možemo reći, jasno je da postoji povezanost sa vakcinom, rekao je Marko Kavaleri

03. ožujak 2021. 1166 sumnji na nuspojave, većina na Pfizerovo cjepivo, Beroš objasnio detalje o nabavi Sputnika https://www.poslovni.hr/hrvatska/dosad- ... vo-4275974

You asked, we answered: Do the COVID-19 vaccines contain aborted fetal cells?

Question: Do the COVID-19 vaccines contain aborted fetal cells?

Answer from infectious diseases expert James Lawler, MD: No, the COVID-19 vaccines do not contain any aborted fetal cells.

However, Pfizer and Moderna did perform confirmation tests (to ensure the vaccines work) using fetal cell lines. And Johnson & Johnson uses fetal cell lines in vaccine development, confirmation and production.

But it's important to have the full context: Fetal cell lines are not the same as fetal tissue.

Fetal cell lines are cells that grow in a laboratory. They descend from cells taken from elective abortions in the 1970s and 1980s. Those individual cells from the 1970s and 1980s have since multiplied into many new cells over the past four or five decades, creating fetal cell lines. Current fetal cell lines are thousands of generations removed from the original fetal tissue. They do not contain any tissue from a fetus.

Vaccine makers may use these fetal cell lines in any of the following three stages of vaccine development:

Development: Identifying what works
Confirmation: Making sure it works
Production: Manufacturing the formula that works

When it comes to the COVID-19 vaccines currently approved for emergency use, neither the Pfizer nor Moderna vaccines used fetal cell lines during the development or production phases. (So, no fetal cell lines were used to manufacture the vaccine, and they are not inside the injection you receive from your doctor.) However, both companies used the fetal cell line HEK 293 in the confirmation phase to ensure the vaccines work. All HEK 293 cells are descended from tissue taken from a 1973 elective abortion that took place in the Netherlands.

The Johnson & Johnson vaccine is a bit different. It is an adenovirus vector vaccine. (Adenovirus is the virus that causes the common cold. The virus in this vaccine has been changed so that it does NOT cause illness.) With this type of vaccine, a carrier, in this case adenovirus, acts as a delivery vehicle. The adenovirus has had the coronavirus spike protein added to its DNA. The adenovirus carries that genetic material into your body, delivering its modified DNA to your cells. Your cells will then make the spike protein, activating your immune system. Once activated, your immune system creates antibodies to fight off the spike protein. Learn more about the Johnson & Johnson vaccine.

To make their virus vector vaccine, Johnson & Johnson infects PER.C6 fetal cell line cells with adenovirus. All PER.C6 cells used to manufacture the Johnson & Johnson vaccine are descended from tissue taken from a 1985 elective abortion that also took place in the Netherlands. They use this cell line because it is a well-studied industry standard for safe and reliable production of viral vector vaccines.

Žao mi je zbog problema oko AstraZeneca cjepiva. Uvjerljivo najjeftinija (10-15x jeftinija od ostalih, obećali su da na njoj neće imati nikakvu dobit), ne zahtijeva skladištenje na -70c. Ne koristi novu mRNA tehnologiju.

Ipak, i uz probleme, zahvaljujući njoj, UK prva ide prema normali.

Izvjesno je da se AZ neće koristiti za osobe ispod 30 ili čak ispod 50 godina, jer su skoro svi slučajevi ugrušaka u krvi javili kod mlađih osoba (a koje uostalom imaju i puno manju opasnost od COVID).

Sljedeće najbolje cjepivo je Novavax, i zbog efektivnosti i zbog relativno tradicionalne tehnologije. Za mene tek dostupno tamo u desetom mjesecu, javim vam jesam li preživio.

..pfizerom se cijepio..nikakvi problema danke deutchland..diviziji i lasici preporučam rusko lakše će se stopit..

Vele u pajseru da ide i treća doza nakon godinu dana, i onda svake godine docijepljivanje...